Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
Nature Biotechnology
|
December 10, 2015
Trade pact blow for innovative drug developers
Chris Morrison
Nature Biotechnology
|
February 6, 2016
Fresh from the biotech pipeline--2015
Chris Morrison
Nature Biotechnology
|
December 8, 2016
Trump election sends aftershocks through biotech sector
Chris Morrison
Nature Biotechnology
|
February 7, 2015
Fresh from the biotech pipeline-2014
Chris Morrison
Nature Biotechnology
|
January 31, 2017
Fresh from the biotech pipeline-2016
Chris Morrison
Nature Reviews. Drug Discovery
|
January 21, 2022
No shortage of fresh IPO capital in 2021
Chris Morrison
Nature Biotechnology
|
January 17, 2020
Fresh from the biotech pipeline-2019
Chris Morrison
Nature Biotechnology
|
November 8, 2014
Illumina, Thermo Fisher build consortia to develop 'universal' cancer tests
Chris Morrison
Nature Biotechnology
|
November 7, 2015
AbbVie buys last available priority voucher for $350 million
Chris Morrison
Nature Biotechnology
|
February 7, 2015
Merck splashes on Cubist, antibiotics prospects brighten
Chris Morrison
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
Nature Biotechnology
|
December 10, 2015
Trade pact blow for innovative drug developers
Chris Morrison
Nature Biotechnology
|
February 6, 2016
Fresh from the biotech pipeline--2015
Chris Morrison
Nature Biotechnology
|
December 8, 2016
Trump election sends aftershocks through biotech sector
Chris Morrison
Nature Biotechnology
|
February 7, 2015
Fresh from the biotech pipeline-2014
Chris Morrison
Nature Biotechnology
|
January 31, 2017
Fresh from the biotech pipeline-2016
Chris Morrison
Nature Reviews. Drug Discovery
|
January 21, 2022
No shortage of fresh IPO capital in 2021
Chris Morrison
Nature Biotechnology
|
January 17, 2020
Fresh from the biotech pipeline-2019
Chris Morrison
Nature Biotechnology
|
November 8, 2014
Illumina, Thermo Fisher build consortia to develop 'universal' cancer tests
Chris Morrison
Nature Biotechnology
|
November 7, 2015
AbbVie buys last available priority voucher for $350 million
Chris Morrison
Nature Biotechnology
|
February 7, 2015
Merck splashes on Cubist, antibiotics prospects brighten
Chris Morrison
Page
of 8